Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High Therapeutic Index.

Vancomycin is a glycopeptide antibiotic that inhibits transpeptidation during cell wall synthesis by binding to the D-Ala-D-Ala termini of lipid II. For long, it has been used as a last resort antibiotic. However, since the emergence of the first vancomycin-resistant enterococci in 1987, vancomycin resistance has become widespread, especially in hospitals.

Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii.

Bacteriophage-encoded endolysins have shown promise as a novel class of antibacterials with a unique mode of action, i.e., peptidoglycan degradation.